Searching. Please wait…
1579
37
171
29274
4420
2604
347
391
Abstract: Double transgenic mice expressing mutant amyloid precursor protein (APPswe) and mutant presenilin 1 (PS1dE9) are a model of Alzheimer-type amyloidosis and are widely used in experimental studies. In the present work, the relationships between brain and plasma amyloid-ß peptide (Aß) levels and cognitive impairments were examined in male APPswe/PS1dE9 double transgenic mice at different ages. When compared with non-transgenic littermates, APPswe/PS1dE9 mice exhibited significant learning deficits from the age of 6months (M6), which were aggravated at later stages of life (M8 and M12). Sporadic brain amyloid plaques were observed in mice as early as M3 and progressively increased in number and size up to M12. A similar increase was observed in brain insoluble Aß levels as assessed by enzyme-linked immunosorbent assay (ELISA). In particular, the levels of brain insoluble Aß peptides rose steeply from M4 to M6. Interestingly, this pronounced amyloid deposition was accompanied by a temporary fall in the concentration of brain soluble and membrane-bound Aß peptides at M6 that rose again at M8 and M12. The plasma levels of Aß40 and Aß42 decreased with advancing age up to M8, when they stabilized at M12. This decrease in plasma Aß levels coincided with the observed increase in insoluble brain Aß levels. These results could be useful for developing plasma Aß levels as possible biomarkers of the cerebral amyloidosis and provide advances in the knowledge of the Aß peptide biochemical changes that occur in the brain of Alzheimer's disease patients.
Fuente: Neuroscience. 2014 Mar 28;263:269-79
Publisher: Elsevier Science
Year of publication: 2014
No. of pages: 11
Publication type: Article
ISSN: 0306-4522,1873-7544
Citations in Google Scholar
IZCO, M
PAULA MARTINEZ FERNANDEZ
ANDREA CORRALES PARDO
FANDOS, N
SUSANA GARCIA CERRO
INSUA, D
MONTAÑÉS, M
PÉREZ GRIJALBA, V
NOEMI RUEDA REVILLA
VERONICA VIDAL SANCHEZ
CARMEN MARTINEZ-CUE PESINI
PESINI, P
SARASA, M
Back